Clinical Characteristics and Outcomes following Percutaneous Coronary Intervention in Unprotected Left Main Disease:

Ștefan Dan Cezar Moț1,2, Adela Mihaela Șerban1,2, Alexandru Achim1,3

  • 1Cardiology Department, Heart Institute Niculae Stăncioiu, 19-21 Motilor Street, 400001 Cluj-Napoca, Romania.

Insights

Percutaneous coronary intervention (PCI) for unprotected left main disease is safe and effective, with no significant difference in success rates between one-stent and two-stent techniques. Fractional flow reserve (FFR) can predict side branch compromise after PCI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Unprotected left main (LM) coronary artery disease poses significant risks due to the large myocardial territory involved.
  • Percutaneous coronary intervention (PCI) offers an alternative to coronary artery bypass grafting (CABG) for LM disease, especially in patients with lower anatomical complexity or contraindications to surgery.

Purpose of the Study:

  • To evaluate the clinical characteristics and outcomes of patients undergoing unprotected LM PCI using either one-stent or two-stent provisional techniques.
  • To assess the predictive value of fractional flow reserve (FFR) for stent enhancement side branch length (SESBL) and correlate angiographic parameters with outcomes.

Main Methods:

  • Retrospective evaluation of 201 patients undergoing unprotected LM PCI (one-stent or two-stent).
  • Assessment of clinical characteristics, cardiovascular risk factors, and procedural outcomes.
  • Analysis of angiographic parameters including LM area (IVUS/OCT), stenosis grade (QCA), side branch FFR, and SESBL.

Main Results:

  • The majority of patients (89.5%) had arterial hypertension and (86.5%) dyslipidemia. The one-stent technique was used in 81.8% of patients, while 18.2% received two stents.
  • Patients requiring two stents more frequently had intermediate SYNTAX scores (69.4%) and needed kissing balloon inflation (KBI) (69.4%).
  • No significant difference in revascularization success was observed between one-stent and two-stent techniques. FFR > 0.86 moderately predicted SESBL > 2 mm (AUC = 0.61).

Conclusions:

  • Unprotected LM PCI is a safe and effective revascularization strategy for complex and high-risk patients.
  • One-stent and two-stent techniques demonstrate comparable revascularization success rates.
  • While KBI did not significantly impact side branch FFR, lower FFR values correlated with angiographic side branch compromise.

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
105
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
15
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
18
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
38
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
17
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
29